Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-01

Clinical Trial Update: Pilot Study: KeraStat® Gel for Topical Delivery of Morphine for Management of Non-Healing, Painful Open Wounds and Ulcers [Phase 4]

View source ↗

Summary

Pilot Phase 4 trial evaluating KeraStat Gel for topical morphine delivery to manage non-healing, painful wounds and ulcers; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • KeraStat Gel

Snippet

Sponsor: The Metis Foundation | Conditions: Wound of Skin, Burns | Phase 4 | Status: RECRUITING